A Gut Feeling
This article was originally published in Start Up
Executive Summary
The gastrointestinal market has traditionally split into two categories: the heartburn diseases GERD and ulcer, and "other." The former category has yielded blockbuster successes for several large companies, including SmithKline Beecham and AstraZeneca. Those markets have plateaued, however, and now companies are casting about for follow-on products in GI. Large companies and small companies have begun to venture into the "other" GI diseases, irritable bowel syndrome, and inflammatory bowel disease. These diseases are all difficult to diagnose, and the mechanisms that underpin them are still unknown. Furthermore, the diseases are multi-factorial, immunological inflammatory diseases and drug discovery is challenging. While waiting for new drugs, many small companies find the market controlled by 10,000 gastroenterologists in the US to be a niche opportunity that represents a large market that can be targeted with a small salesforce. Device companies too have a role to play, in giving gastros new procedures that keep patients in their franchise, which is encroached upon by GPs and general surgeons.
You may also be interested in...
STM Medizintechnik GMBH
Given all of the interest in technologically innovative ways to do colon examinations today, from virtual colonoscopies using computerized tomography to imaging systems contained in small pills that patients swallow, a la Given Imaging Ltd., the technology that Heidelberg, Germany-based STM Medizintechnik GMBH has developed seems hopelessly conventional: yet another variant on a traditional endoscope. But STM officials argue that their device has the look and feel of a device that physicians are already comfortable with, combined with innovative features that solve several of the limitations of traditional endoscopy that led device companies, and their customers, in search of new approaches.
The New Wave in Gastroenterology
Gastroenterology, once a market comprised of large, reusable pieces of equipment like endoscopes, ushers in a new era of minimally invasive surgical disposables. Indeed, minimally invasive procedures make it possible for surgical devices to encroach upon drug franchises in several multi-billion dollar markets, including gastroesophageal reflux disease and obesity.
MediGus Ltd.
MediGus Ltd. combines an endoscopic stapler with a miniaturized ultrasonic sighting system in a tool designed to permit surgeons to convert open or laparoscopic surgeries to least-invasive endoscopic surgeries.